Literature DB >> 3058021

Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii.

Y J Yang1, D M Livermore.   

Abstract

Indole-positive members of the Proteeae usually have inducible expression of chromosomal beta-lactamases. Mutants with stably derepressed beta-lactamase expression occur in inducible populations at frequencies in the range of 10(-6) to 10(-8). The contribution of these beta-lactamases to drug resistance was examined in Morganella morganii and Proteus vulgaris. The M. morganii enzyme was a high-molecular-weight (49,000) class I cephalosporinase with low Vmax rates for ampicillin, carbenicillin, and and broad-spectrum cephalosporins. The P. vulgaris enzyme had a lower molecular weight (32,000) and high Vmax rates for ampicillin, cephaloridine, cefotaxime, and ceftriaxone. Imipenem and cefoxitin inactivated the P. vulgaris enzyme but were low-Vmax, low-Km substrates for that of M. morganii. Despite these differences, the two beta-lactamases caused similar resistance profiles. Ampicillin and cephaloridine were strong inducers for both species, and beta-lactamase-inducible strains and their stably derepressed mutants were resistant, whereas basal mutants (those with low-level uninducible beta-lactamase) were susceptible to these two compounds. Mezlocillin, cefotaxime, ceftriaxone, and (usually) carbenicillin were almost equally active against beta-lactamase-inducible organisms and their basal mutants, but were less active against stably derepressed mutants. This behavior reflected the beta-lactamase lability of these drugs, coupled with their weak inducer activity below the MIC. Carbenicillin was a labile strong inducer for a single P. vulgaris strain, and inducible enzyme was protective against the drug in this atypical organism. Cefoxitin and imipenem, both strong inducers below the MIC, were almost equally active against beta-lactamase-inducible organisms and their basal and stably derepressed mutants.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3058021      PMCID: PMC175873          DOI: 10.1128/AAC.32.9.1385

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Modified peptidoglycan transpeptidase activity in a carbenicillin-resistant mutant of Pseudomonas aeruginosa 18s.

Authors:  N A Curtis; C Brown; M Boxall; M G Boulton
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors:  M H Richmond; R B Sykes
Journal:  Adv Microb Physiol       Date:  1973       Impact factor: 3.517

4.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

Review 5.  The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.

Authors:  R B Sykes; M Matthew
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

Review 6.  Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future.

Authors:  C C Sanders; W E Sanders
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

7.  A set of bacterial strains for evaluation of beta-lactamase-stability of beta-lactam antibiotics.

Authors:  T Sawai; T Yoshida; K Tsukamoto; S Yamagishi
Journal:  J Antibiot (Tokyo)       Date:  1981-10       Impact factor: 2.649

8.  Characterization of eight beta-lactamases of Gram-negative bacteria.

Authors:  T Sawai; M Kanno; K Tsukamoto
Journal:  J Bacteriol       Date:  1982-11       Impact factor: 3.490

9.  Purification and some properties of a cephalosporinase from Proteus vulgaris.

Authors:  N Matsubara; A Yotsuji; K Kumano; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

10.  Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.

Authors:  T Sawai; K Tsukamoto
Journal:  J Antibiot (Tokyo)       Date:  1982-11       Impact factor: 2.649

View more
  10 in total

1.  Integron- and carbenicillinase-mediated reduced susceptibility to amoxicillin-clavulanic acid in isolates of multidrug-resistant Salmonella enterica serotype typhimurium DT104 from French patients.

Authors:  L Poirel; M Guibert; S Bellais; T Naas; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.

Authors:  G S Babini; M Yuan; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 3.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

Review 4.  The development of beta-lactam antibiotics in response to the evolution of beta-lactamases.

Authors:  S Y Essack
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

5.  Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates.

Authors:  L Poirel; M Guibert; D Girlich; T Naas; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 6.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

7.  Molecular characterization of a TEM-21 beta-lactamase in a clinical isolate of Morganella morganii.

Authors:  F Tessier; C Arpin; A Allery; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

8.  Biochemical and molecular characterization of three new variants of AmpC beta-lactamases from Morganella morganii.

Authors:  Pablo Power; Moreno Galleni; Juan A Ayala; Gabriel Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

9.  Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.

Authors:  Shazad Mushtaq; Yigong Ge; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

10.  Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities.

Authors:  Moayad Alhariri; Majed A Majrashi; Ali H Bahkali; Faisal S Almajed; Ali O Azghani; Mohammad A Khiyami; Essam J Alyamani; Sameera M Aljohani; Majed A Halwani
Journal:  Int J Nanomedicine       Date:  2017-09-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.